AI assistant
Sending…
AEHR TEST SYSTEMS — Director's Dealing 2022
Sep 21, 2022
32300_dirs_2022-09-21_20b48ae6-5793-46fc-a526-c50487ae0f1c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AEHR TEST SYSTEMS (AEHR)
CIK: 0001040470
Period of Report: 2022-09-20
Reporting Person: RICHMOND DONALD P. II (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-09-20 | Common Stock | M | 10000 | $1.68 | Acquired | 139153 | Direct |
| 2022-09-20 | Common Stock | M | 6000 | $3.93 | Acquired | 145153 | Direct |
| 2022-09-20 | Common Stock | M | 34000 | $2.42 | Acquired | 179153 | Direct |
| 2022-09-20 | Common Stock | M | 34000 | $2.4 | Acquired | 213153 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-09-20 | Incentive Stock Option (right to buy) | $1.68 | M | 10000 | Disposed | 2023-07-25 | Common Stock (10000) | Direct |
| 2022-09-20 | Incentive Stock Option (right to buy) | $2.4 | M | 34000 | Disposed | 2025-08-17 | Common Stock (34000) | Direct |
| 2022-09-20 | Incentive Stock Option (right to buy) | $2.42 | M | 34000 | Disposed | 2025-03-25 | Common Stock (34000) | Direct |
| 2022-09-20 | Incentive Stock Option (right to buy) | $3.93 | M | 6000 | Disposed | 2024-07-11 | Common Stock (6000) | Direct |
Footnotes
F1: The amount reported includes shares subject to unvested restricted stock units.
F2: One forty-eighth (1/48) of the total number of shares became exercisable on this date and an additional one forty-eighth (1/48) of the total number of shares became exercisable each month thereafter.
More from AEHR TEST SYSTEMS
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 13
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Major Shareholding Notification
2026
Feb 9
Director's Dealing
2026
Feb 4